Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00963001 · ClinicalTrials.gov registry record · Phase 1
Effect of Food on the Pharmacokinetics of Oral Treprostinil
A Phase 1 study, sponsored by United Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT00963001 is a Phase 1 study that has completed, run by United Therapeutics. The registered enrollment target is 32 participants.
The verdict
NCT00963001, a Phase 1 study, has completed, sponsored by United Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the pharmacokinetic and safety profile of a single dose of oral treprostinil following four different meals of varying caloric and fat content.
Interventions
- DRUG Treprostinil diethanolamine
- OTHER Standardized meals
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2009-09 |
| Est. Completion | 2009-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00963001
The ClinicalTrials.gov registry entry for NCT00963001 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is United Therapeutics, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Treprostinil diethanolamine is the first listed.
NCT00963001 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00963001 about?
NCT00963001 is a clinical study titled "Effect of Food on the Pharmacokinetics of Oral Treprostinil". The purpose of this study is to assess the pharmacokinetic and safety profile of a single dose of oral treprostinil following four different meals of varying caloric and fat content.
What is the current status of trial NCT00963001?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2009-09. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00963001?
The interventions under investigation include: Treprostinil diethanolamine (DRUG), Standardized meals (OTHER).
Who is sponsoring clinical trial NCT00963001?
This trial is sponsored by United Therapeutics, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.